AIM ImmunoTech Inc. (AIM) Market Value
The asset value of AIM ImmunoTech (AIM), which stands at 0.01 as tracked on the chart, is based on the sale of the unique drug Ampligen, which holds high value due to a lack of alternatives. However, global conflicts and sanctions are complicating the logistics of biomaterials, hindering international trials. Meanwhile, demand is rising due to long-COVID therapies, although prolonged validations of new treatment methods are temporarily constraining the company's expansion.
Metric breakdowns and analytics for AIM ImmunoTech, Inc. (AIM)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
Total Debt to Capital AIM ImmunoTech|AIM - Long-Term Debt to Capital|Short-Term Debt to Equity AIM ImmunoTech|AIM - Aggregate Debt Obligations|Debt to Book Capitalization Ratio AIM ImmunoTech Inc.|AIM - Company Long-Term Liabilities|Company Short-Term Debts AIM ImmunoTech|Quick Liquidity Indicator aimimmuno.com
- business earnings and investment ratios data:
AIM - Final Profit|Projected Future Earnings AIM ImmunoTech|AIM - Business Payback Period|Future Price to Earnings AIM ImmunoTech Inc.|AIM - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AIM ImmunoTech Inc.|AIM - Operating profit before deduction of amortization|Net earnings per share for the last 12 months AIM ImmunoTech|AIM - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months aimimmuno.com|AIM - Earnings per share growth this year|Earnings growth forecast for next year AIM ImmunoTech
Summary company analysis:AIM (AIM ImmunoTech Inc.)
Market capitalization aggregates the value of all shares, reflecting the current scale of the business in monetary terms. This metric serves as a liquidity stress-testing tool when building large positions. Analyzing the company's aggregate market valuation allows for the identification of capital stagnation phases. For AIM ImmunoTech (AIM), this indicator is sensitive to operational risks. A change in manufacturing partners could temporarily destabilize quotes until supply chains are restored.
Competitors of AIM ImmunoTech (AIM)
Market Capitalization ARGX (argenx)|Market Capitalization BioNTech Inc. (BNTX)|ABVX - Market Value|ADMA Corp (ADMA) - Market Valuation|Protagonist Therapeutics (PTGX) - Market Value|Market Valuation IMVT (immunovant.com)|KNSA (Kiniksa) - Market Capitalization|GRFS: Market Value|Market Capitalization ADPT|Market Capitalization Celldex Corp (CLDX)|Market Value Aurinia Pharmaceuticals AUPH|Market Value BCRX|VERA - Market Value|Dianthus Therapeutics Inc (DNTH) - Market Valuation|PHVS: Market Capitalization|AbCellera Biologics Inc. (ABCL) - Market Capitalization|Market Valuation TRML|PGEN: Market Value|Market Capitalization PHAR|Market Capitalization Nektar Therapeutics Inc|Market Value Upstream Bio Corp UPB|ZBIO - Market Valuation|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KALV (KalVista Pharmaceuticals, Inc.) - Market Valuation|Septerna, Inc. (SEPN) - Market Capitalization|Market Value Pieris Pharmaceuticals Inc|Market Capitalization SVRA (Savara Pharma)|Market Capitalization RIGL|ANAB - Market Value|Market Capitalization ATXS (Astria Therapeutics, Inc.)|Market Capitalization enGene Holdings Inc ENGN|RAPT Therapeutics - Market Capitalization|Market Capitalization Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics (ACRS) - Market Value|Market Valuation kyvernatx.com|Market Valuation TLSA|CABA: Market Value|Market Capitalization VTYX|Market Capitalization Theratechnologies, Inc|Market Value Avalo Therapeutics, Inc AVTX|ELDN - Market Valuation|AGEN - Market Value|Climb Bio Inc. (CLYM) - Market Valuation|ZURA (Zura Bio) - Market Valuation|aTyr Pharmaceuticals (ATYR) - Market Capitalization|Market Value Adagene Inc|Market Capitalization IMA (Ikena Oncology, Inc.)|Market Value Shattuck Labs, Inc. (STTK)|EQ - Market Value|Connect Biopharma Holdings Limited - Market Valuation|Market Value IMUX (Immunic Therapeutics)|Atara Biotherapeutics Inc - Market Capitalization|Market Value InflaRx N.V.|XFOR: Market Capitalization|Market Valuation Adicet Bio, Inc.|CELU (Celularity Inc) - Market Capitalization|INMB: Market Value|Market Capitalization BRNS|Market Capitalization kezarlifesciences.com (KZR)|Market Capitalization SABS (SAB Biotherapeutics, Inc.)|Market Capitalization Akari Therapeutics PLC (AKTX)|ENLV - Market Value|Q32 Bio Inc. (QTTB) - Market Valuation|GeoVax Labs, Inc. (GOVX) - Market Value|Market Valuation EDSA (edesabiotech.com)|IBIO (iBio) - Market Capitalization|CARM: Market Value|Market Capitalization XTLB|Market Capitalization boltbio.com (BOLT)|Market Value HCW Biologics HCWB|Market Value APVO|ADTX - Market Value|GRI Bio Inc (GRI) - Market Valuation|XRTX: Market Capitalization|Vyome Therapeutics (HIND) - Market Capitalization|Market Valuation REVB|INDP: Market Value|Market Capitalization SCNI|Market Capitalization calcimedica.com|Market Value Affimed N.V. AFMD|ALLK - Market Valuation|HOOK - Market Value|IGM Biosciences, Inc. (IGMS) - Market Valuation|ITOS (iTeos Therapeutics, Inc.) - Market Valuation|Ocean Biomedical Inc (OCEA) - Market Capitalization|Market Value TC BioPharm (Holdings) PLC|Market Capitalization THRD (Third Harmonic Bio Inc)
